Andreas Zimprich-Foundation

Andreas Zimprich died of a brain tumor at the age of 48. His parents Marianne and Egon Zimprich established the Andreas Zimprich-Foundation in his memory together with the German Cancer Research Center. The benefactors from Heilbronn would like to advance research in the field of neuro-oncology. Patients with glioma should have better chances in the future for a successful treatment than their son. Since 2010 the foundation has been committed to promoting the development of innovative methods of treatment for brain tumors.

The 2019 Andreas Zimprich-Prize was awarded to Erik Jung. The award winner works as a physician at the Neurological Department at the Heidelberg University Hospital and as a scientist at the German Cancer Research Center. In his dissertation, he investigated novel therapeutic approaches for malignant gliomas.

In 2017 the Andreas Zimprich-Prize was awarded to Christoph Geisenberger. He received the award for his research on the biological properties of glioblastomas, associated with long-term survival. His research was carried out in the Neurosurgical Clinic at the University Hospital in Heidelberg.

The photo shows the prizewinner for 2017 (left) together with other prize-winning scientists, at the award ceremony held at the German Cancer Research Center.

The first prizewinner in 2015 was Lukas Bunse, physician and scientist at the Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology at DKFZ and the University Hospital Heidelberg. In his doctoral thesis, Lukas Bunse focused on the development of a vaccine against brain tumors.

The photo shows the prizewinner 2015 (middle) together with the Scientific Director of DKFZ, Prof. Michael Boutros (far left), the Laudatory Speaker Prof. Wolfgang Wick (second from the right) as well as Andreas Zimprich’s brother and father (far right).